Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Knowing when to save and when to invest is crucial for financial success. Learn how to optimize your strategy for maximum returns.
28,655 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Apollo Global Management posted strong 2025 revenue and raised its dividend, but the stock has fallen as private cred...
Two Wall Street giants raised price targets on Super Micro Computer after a solid Q3 2026 performance, but neither mo...
Aramco’s chief executive warned that the oil market won’t return normal this year if the Iran conflict isn’t resolved...
A new AI-driven forecast puts Solana on a trajectory to smash expectations by late 2026, driven by on-chain adoption ...
Vanguard's VTWO and iShares' IWM both mirror the Russell 2000, but over 10 years VTWO's return outpaces IWM by roughl...
AI-related debt now accounts for about 15% of the debt corporate bond market, signaling a shift that could alter risk...
As visa rules tighten, a growing share of U.S. firms with immigrant leaders are scrambling to secure continuity throu...
Pension funds are aggressively loading up on the Vanguard Intermediate-Term Government Bond ETF, a move that highligh...
ETH fell below the $2,000 level, renewing talk of further declines. Market metrics and crowd sentiment suggest the do...
A fresh examination argues that high earners may favor traditional pre-tax employer matches over Roth options in peak...
Newly listed Roundhill DRAM ETF faces a volatile late-year backdrop as contract pricing and hyperscaler demand swing ...